Stereoisomeric Pam<sub>2</sub>CS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvants.

Stereoisomeric Pam₂CS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvants.

Kaur, Arshpreet; Piplani, Sakshi; Kaushik, Deepender; Fung, Johnson; Sakala, Isaac G; Honda-Okubo, Yoshikazu; Mehta, Surinder K; Petrovsky, Nikolai; Salunke, Deepak B.

Afiliação

Kaur A; Department of Chemistry and Centre for Advanced Studies, Panjab University Chandigarh India salunke@pu.ac.in.
Piplani S; Vaxine Pty Ltd Warradale Australia.
Kaushik D; College of Medicine and Public Health, Flinders University Adelaide Australia nikolai.petrovsky@flinders.edu.au.
Fung J; Department of Chemistry and Centre for Advanced Studies, Panjab University Chandigarh India salunke@pu.ac.in.
Sakala IG; Vaxine Pty Ltd Warradale Australia.
Honda-Okubo Y; College of Medicine and Public Health, Flinders University Adelaide Australia nikolai.petrovsky@flinders.edu.au.
Mehta SK; Vaxine Pty Ltd Warradale Australia.
Petrovsky N; College of Medicine and Public Health, Flinders University Adelaide Australia nikolai.petrovsky@flinders.edu.au.
Salunke DB; Vaxine Pty Ltd Warradale Australia.

RSC Med Chem ; 13(5): 622-637, 2022 May 25.

Article em En | MEDLINE | ID: mdl-35694694

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: RSC Med Chem Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: RSC Med Chem Ano de publicação: 2022 Tipo de documento: Article